 We are a clinical trials research center in the Department of Neurology at UCLA devoted to finding new treatments for patients with brain disorders.
Founded in 2004 by Kate Edelman Johnson and Jeffrey L. Cummings, M.D., the center provides advanced academic expertise and resources, clinical trials support, and educational programs. For more about JCNT, click here. JCNT researchers uphold our values of excellence, integrity, and service to create patient-centered quality care for the patients we serve. We provide high quality research by protecting the rights and welfare of the patients. | | Read more... |
| | Current JCNT Clinical Trials |
The primary role of JCNT is to promote vital clinical trials research in neurological diseases such as Alzheimer’s disease and stroke | | Read more... |
|
| | UCLA Neurology is #1 in the Nation in National Institutes of Health (NIH) Funding |
 The Neurology Department at The David Geffen School of Medicine at UCLA received the most NIH funding to conduct research and sponsor fellowships.
Please visit the NIH web site for more details |
|
|
|
|
|
JCNT hosts special events to raise funds and increase awareness for neurotherapeutic research. |
|
Read more...
|
|
|
UCLA Medical Center Rated Among Top Five Hospitals in America |
|
 Best in West for 17th Consecutive Year in U.S. News & World Report Survey
UCLA Medical Center ranks as one of the top five American hospitals—and the best hospital in the western United States for the 17th consecutive year—according to a U.S. News & World Report survey that reviewed patient outcomes data, reputation among physicians and other care-related factors. |
|
Read more...
|
|
|
Help advance treatments for neurological diseases by bidding on (purchasing) one-of-a-kind holiday gifts, such as:
